Clinical Trials Directory

Trials / Conditions / Polyneuropathies

Polyneuropathies

34 registered clinical trials studyying Polyneuropathies12 currently recruiting.

StatusTrialSponsorPhase
RecruitingAccuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for t
NCT07515989
University of BrasiliaN/A
Not Yet RecruitingTo Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (
NCT07116473
Eidos Therapeutics, a BridgeBio companyPhase 3
RecruitingUltrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
NCT07166302
Masaryk University
RecruitingAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers
NCT06563895
Eidos Therapeutics, a BridgeBio companyPhase 3
RecruitingDiagnostic Feasibility of 100 Hz Tetanic Stimulation
NCT06754995
University of Debrecen
RecruitingA Phase 3 Study of NTLA-2001 in ATTRv-PN
NCT06672237
Intellia TherapeuticsPhase 3
RecruitingUsing the EHR to Advance Genomic Medicine Across a Diverse Health System
NCT06377033
University of PennsylvaniaN/A
Not Yet RecruitingUltrasonography in Diagnosis of Polyneuropathy
NCT06390527
University Medical Centre Ljubljana
RecruitingPrognostic Value of Biomarkers in Polyneuropathy.
NCT06044662
Rigshospitalet, Denmark
Enrolling By InvitationAssessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy i
NCT06359561
Rijnstate Hospital
RecruitingPolyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
NCT06040567
Rigshospitalet, Denmark
CompletedChatGPT in the Diagnosis and Management of Complex Polyneuropathies: Comparative Analysis With Neurologists Us
NCT07493681
Istituto Clinico Humanitas
Active Not RecruitingSpectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisira
NCT05023889
Austin Neuromuscular CenterEARLY_Phase 1
CompletedSensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Tr
NCT04664426
University Medical Center Groningen
UnknownPolyneuropathy and COVID-19
NCT05188690
Fondazione Don Carlo Gnocchi Onlus
UnknownPhysical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument
NCT04461613
Oslo University HospitalN/A
RecruitingExploring the Genetics of Neuropathic Pain
NCT03862365
Oslo University Hospital
CompletedEffect of Exercise and Surgical Weight Loss on Polyneuropathy
NCT03617185
University of MichiganN/A
CompletedTRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
NCT03237494
CENTOGENE GmbH Rostock
CompletedElectrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septi
NCT03765489
University of ChileN/A
UnknownPeripheral Physiological Measures as Determinants of Pain Risk
NCT02985294
Neuroscience Technologies SLP, Barcelona
UnknownChemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
NCT02753036
Charite University, Berlin, Germany
UnknownNational Registry for Egyptian Pediatric Neuromuscular Diseases
NCT02124616
Ain Shams University
UnknownCost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes
NCT02061059
Maastricht UniversityN/A
UnknownNeurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy
NCT01718015
Aarhus University Hospital
CompletedNeurogenic Inflammation in Diabetes
NCT01370837
Maastricht University Medical CenterN/A
CompletedNeuropathic Pain Management
NCT01263132
Merck KGaA, Darmstadt, GermanyPhase 3
CompletedEscitalopram as a Treatment for Pain in Polyneuropathy
NCT00162968
Odense University HospitalPhase 4
TerminatedThe Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/
NCT01867645
Medical University of ViennaPhase 1
CompletedRituximab to Treat Neuropathy With Anti-MAG Antibodies
NCT00050245
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
CompletedA Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With
NCT00231673
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
No Longer AvailableIndividual Patient Expanded Access IND to Treat Polyneuropathy
NCT04064983
Hope Biosciences Research Foundation
TerminatedAn Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NCT00089557
NeurogesXPhase 2
CompletedTolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropat
NCT00082316
NeurogesXPhase 2